GeneReach Biotechnology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Grace Chang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 6.3yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
Does GeneReach Biotechnology (GTSM:4171) Have A Healthy Balance Sheet?
Apr 18
Will Weakness in GeneReach Biotechnology Corp.'s (GTSM:4171) Stock Prove Temporary Given Strong Fundamentals?
Feb 28We Like GeneReach Biotechnology's (GTSM:4171) Returns And Here's How They're Trending
Jan 31The GeneReach Biotechnology (GTSM:4171) Share Price Is Up 596% And Shareholders Are Delighted
Dec 27
GeneReach Biotechnology Corp.'s (GTSM:4171) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 28CEO
Grace Chang
no data
Tenure
Ms. Grace Chang, Ph D., serves as Chief Executive Officer at GeneReach Biotechnology Corp. Ms. Chang holds Ph.D. in Nutritional Science and Toxicology from UC Berkeley in the year 1993 to 1998 and B.S. in...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | no data | no data | no data | |
| Chief Operation Officer | 4.3yrs | no data | no data | |
| Chief Technology Officer | 6.3yrs | no data | no data | |
| Vice President of Compliance Operation | no data | no data | no data | |
| Chief Commercial Officer | 6.3yrs | no data | no data |
6.3yrs
Average Tenure
Experienced Management: 4171's management team is seasoned and experienced (6.3 years average tenure).